For Company Research, enter symbol or keyword and choose type of research:    Symbol Search
Iovance Biotherapeutics Inc
(NASDAQ: IOVA) Add to Portfolio
$20.72
-0.06 (-0.29%)
as of Sep 19, 2019

Last 20.72
Change -0.06 (-0.29%)
Open 20.72
Prev. Close 20.78
Today's Range
20.59 21.45
52wk Range
7.26 26.59
Volume 1,215,197
Avg Volume 1,142,185
Sector SIC-2836 Biological Products, (No Disgnostic Substanc

Recent Headlines
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, today announced that the company plans to present at (full story)
IOVA: 20.72 (-0.06)
The "Tumor Infiltrating Lymphocytes: A New Frontier in Cancer Immunotherapy" report has been added to ResearchAndMarkets.com's offering. (full story)
IOVA: 20.72 (-0.06)
- Regulatory submission for LN-145 in advanced cervical cancer expected in the second half of 2020 - (full story)
IOVA: 20.72 (-0.06)
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, today announced that it will report its second quart (full story)
IOVA: 20.72 (-0.06)
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, today announced the appointment of Friedrich Graf Fi (full story)
IOVA: 20.72 (-0.06)
 
Performance Comparison
Name Today 3-Month 1-Year
IOVA -0.29% -13.77% +51.79%
Growth Rates
YTD +134.12%
1-Year +53.36%
3-Year +160.08%
5-Year +196.86%
© 2019 Market data provided and hosted by Barchart Market Data Solutions. Fundamental company data provided by Morningstar and Zacks Investment Research. SEC Filings provided by Edgar Online. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.